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Abstract
Silver (AgNPs) and maghemite, i.e., superparamagnetic iron oxide nanoparticles (SPIONs) are promising candidates for new
medical applications, which implies the need for strict information regarding their physicochemical characteristics and behavior in a
biological environment. The currently developed AgNPs and SPIONs encompass a myriad of sizes and surface coatings, which
affect NPs properties and may improve their biocompatibility. This study is aimed to evaluate the effects of surface coating on
colloidal stability and behavior of AgNPs and SPIONs in modelled biological environments using dynamic and electrophoretic
light scattering techniques, as well as transmission electron microscopy to visualize the behavior of the NP. Three dispersion media
were investigated: ultrapure water (UW), biological cell culture medium without addition of protein (BM), and BM supplemented
with common serum protein (BMP). The obtained results showed that different coating agents on AgNPs and SPIONs produced
different stabilities in the same biological media. The combination of negative charge and high adsorption strength of coating
agents proved to be important for achieving good stability of metallic NPs in electrolyte-rich fluids. Most importantly, the presence
of proteins provided colloidal stabilization to metallic NPs in biological fluids regardless of their chemical composition, surface
structure and surface charge. In addition, an assessment of AgNP and SPION behavior in real biological fluids, rat whole blood
(WhBl) and blood plasma (BlPl), revealed that the composition of a biological medium is crucial for the colloidal stability and type
of metallic NP transformation. Our results highlight the importance of physicochemical characterization and stability evaluation of
metallic NPs in a variety of biological systems including as many NP properties as possible.
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Introduction
Functional nanomaterials, including nanoparticles, nanocrystals,
and nanoclusters, are promising tools for new medicinal appli-
cations, particularly for clinical use in disease diagnosis and
treatment [1,2]. However, only a few nanomaterials are current-
ly in use for medical purposes [3], for example silver nanoparti-
cles (AgNPs) and superparamagnetic iron oxide nanoparticles
(SPIONs). AgNPs are exploited in medicine for biocidal
therapy owing to their antibacterial, antifungal, antiviral, and
anti-inflammatory properties. In addition, they attract great
interest for application in a variety of other commercial prod-
ucts, such as mobile phones, textiles, food storage containers,
refrigerators, and cosmetics [1,2]. SPIONs are exploited in nu-
merous in vitro and in vivo biomedical applications, but the
most important is their use in imaging and drug delivery
systems [4]. The biomedical applications of AgNPs and
SPIONs imply uptake into the body, which consequently leads
to interactions with protein-containing biological fluids [5,6].
Therefore, it is of increasing interest to systematically collect
detailed information on their physicochemical properties and
behavior in a biological environment. Despite a considerable
number of studies on the colloidal stability of AgNPs and
SPIONs in cell culture media, in natural water, or in the formu-
lation of consumer products [2,7-14], general conclusions and a
clear understanding of their fate in living organisms are still
lacking.
In comparison to the bulk material, the colloidal stability of the
nanoparticulate form of metal is usually more complicated. In
colloidal systems, there are several possible interactions be-
tween the surface atoms of NPs and the molecules present in the
media like dissolution, adsorption, binding, and aggregation, all
influencing biological impacts by affecting reactive oxygen
species generation, cellular uptake and NP biodistribution [15-
18]. Metallic NPs usually aggregate in media with high elec-
trolyte content that correspond to biological fluids [19-27]. NP
agglomeration is intended in some applications, such as in
immunoassays [28], while many others require stable colloidal
dispersions of NPs at high physiological ionic strength [29].
Stabilization of metallic NPs at high electrolyte content, i.e., in
biological media, may be achieved by electrostatic or steric
repulsions [30-32].
Various types of surface coatings have been shown to affect NP
properties, particularly to improve their biocompatibility and
stability against agglomeration [30,33-35]. Proteins or biologi-
cally-compatible surfactants may serve as desirable barriers
preventing NPs from agglomeration in biomedical applications
[18]. Moreover, when NPs enter a biological fluid, electrostatic,
dispersive, and covalent interactions cause proteins to adsorb on
NP surfaces, leading to the formation of a dynamic protein
corona [30,36-38]. The nature and the concentration of these
proteins not only determine the behavior and biological identity
of the NPs, but consequently biouptake, biodistribution and
possible unwanted biological side effects [39-41]. It has already
been shown that the size of the NP correlates with the uptake
and toxicity of metallic NPs [41,42], whereas differences in sur-
face coatings influence cytotoxicity and surface charge [43].
However, it is still unclear how different surface coatings affect
the interaction of NPs with biological environments and the for-
mation of the protein corona.
Because AgNPs and SPIONs with various coatings are used in
many nanotherapeutic and consumer products [44], it has
become critical to fill the knowledge gap surrounding the mech-
anisms of colloidal destabilization including the role of surface
coating in the biocompatibility of metallic NP. The systemati-
cally collected and thoroughly analyzed data presented in this
study will provide further insight into the behavior of AgNPs
and SPIONs in complex biological media and the influence of
surface properties on their colloidal stability. Furthermore, the
obtained results contribute to the understanding of principal
factors governing the behavior of metallic NPs in modelled and
real biological fluids.
The aim of this study was to analyze the colloidal stability and
behavior of differently coated AgNPs and SPIONs under condi-
tions close to those found in biological fluids. A systematic in-
vestigation was performed using a set of eight kinds of AgNPs
and three kinds of SPIONs, each of similar size but stabilized
with different surface coatings. For the purpose of systematic
investigation, surface coatings were chosen following several
criteria: (a) to include non-ionic as well as positively and
negatively charged coatings, (b) to employ coatings of
different chemical functionality, i.e., polymers, surfactants,
small ionic molecules, (c) to include coatings of different
hydrophilic–hydrophobic balance in molecular structure. The
selected coating agents enabled us to investigate the influence
of electrostatic and/or steric effects on the stabilization of NPs.
Thus, AgNPs were produced with the following coatings
(Figure 1): trisodium citrate (CITAgNP), sodium bis(2-ethyl-
hexyl) sulfosuccinate (AOTAgNP), cetyltrimethylammonium
bromide (CTAAgNP), poly(vinylpyrrolidone) (PVPAgNP),
poly(L-lysine)  (PLLAgNP),  bovine serum albumin
(BSAAgNPs) ,  Br i j  35  (Bri jAgNP)  and Tween 20
(TweenAgNP). The SPIONs were prepared as uncoated
γ-Fe2O3 NPs (UNSPIONs), and coated with D-mannose
(MANSPIONs) or poly(L-lysine) (PLLSPIONs). Three media
for NP dispersion were investigated: ultrapure water (UW), bio-
logical cell culture medium without addition of protein (BM),
and BM supplemented with common serum protein (BMP). In
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Figure 1: Experimental setup for stability evaluation of differently coated metallic nanoparticles in different media (UW - ultrapure water, BM - biologi-
cal cell culture medium without addition of protein, BMP - BM supplemented with common serum protein).
addition, the behavior of NPs was investigated in real biologi-
cal fluids: whole blood (WhBl) and blood plasma (BlPl) taken
from Wistar rats. Dulbecco’s modified Eagle’s medium
(DMEM), as a common cell culture medium for a broad range
of mammalian cells, was used as a model biological fluid.
Bovine serum albumin (BSA) served as a model serum protein
due to its biological relevance and high significance in biomedi-
cal applications. Albumin is the most abundant protein in
mammalian blood plasma and has outstanding buffering ability
[3,45]. In addressing the effects of surface coating on the
stability and behavior of NPs in selected model biological envi-
ronments, three types of widely used measurement techniques
were employed: dynamic light scattering (DLS), elec-
trophoretic light scattering (ELS) and transmission electron
microscopy (TEM). We expect our results to be applicable in a
wide variety of different NP types, allowing for robust interpre-
tation and predictive tools in nanobioscience and nanobiotech-
nology.
Results and Discussion
In this study, the role of surface coating agents on the behavior
of well-characterized silver and superparamagnetic iron oxide
NPs [46] in different biological environments was investigated
in adherence to the experimental scheme presented in Figure 1.
Characteristics of prepared AgNPs and
SPIONs
As the first step, the physicochemical properties of freshly syn-
thesized NPs were carefully evaluated in UW using DLS, ELS
and TEM. Table 1 and Table 2 summarize the hydrodynamic
diameters (dH) obtained for both volume- and intensity-
weighted distributions of differently coated AgNPs and SPIONs
under study. DLS measurements in UW showed that both the
volume and the intensity size distributions were monomodal
only for AOTAgNPs. Volume-weighted size distributions were
bimodal for all of the other investigated NPs, with the excep-
tion of CTAAgNPs for which distributions showed three peak
Beilstein J. Nanotechnol. 2016, 7, 246–262.
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Table 1: Hydrodynamic diameter (dH) obtained from size distributions by volume and intensity of differently coated silver nanoparticles in ultrapure
water (UW) and biological medium (BM) after 1 h at 25 °C. Coating agents: trisodium citrate (CITAgNP), sodium bis(2-ethylhexyl) sulfosuccinate
(AOTAgNP), poly(vinylpyrrolidone) (PVPAgNP), Brij 35 (BrijAgNP), Tween 20 (TweenAgNP), bovine serum albumin (BSAAgNP), poly(L-lysine)
(PLLAgNP), and cetyltrimethylammonium bromide (CTAAgNP).
NPs type medium dH (nm) % mean volume dH (nm) % mean intensity
CITAgNPs
UW
12.1 ± 2.8 97.1 15.0 ± 1.8 11.6
96.3 ± 10.3 2.7 144.3 ± 11.7 87.8
BM
13.4 ± 2.5 85.5 16.1 ± 2.9 8.0
63.3 ± 7.2 14.1 101.4 ± 16.3 89.9
AOTAgNPs
UW 19.9 ± 0.5 99.4 27.8 ± 0.4 96.5
BM
409.0 ± 74.1 93.2 295.4 ± 75.0 98.4
5351 ± 128 7.3 5144 ± 228 2.0
PVPAgNPs
UW
4.9 ± 1.7 98.7 6.2 ± 1.1 11.3
33.5 ± 4.0 1.2 69.5 ± 2.9 86.5
BM
4.1 ± 1.3 98.5 5.4 ± 1.4 9.2
37.9 ± 2.6 1.6 78.9 ± 10.7 89.4
BrijAgNPs
UW
24.1 ± 14.3 62.1 26.9 ± 2.1 2.4
129.3 ± 56.4 37.6 164.7 ± 4.8 97.4
BM
269.5 ± 25.6 82.5 246.9 ± 19.2 91.5
56.5 ± 7.9 10.2 56.5 ± 10.8 3.4
5220 ± 126 7.5 4974 ± 219 4.5
TweenAgNPs
UW
5.5 ± 0.3 98.8 6.9 ± 0.5 20.4
36.1 ± 2.5 1.2 68.9 ± 3.6 79.3
BM
11.3 ± 2.4 92.6 13.7 ± 3.1 7.8
98.3 ± 15.9 4.5 143.7 ± 38.9 84.2
5019 ± 307 3.7 4448 ± 543 7.2
BSAAgNPs
UW
12.8 ± 8.1 89.8 85.9 ± 22.3 96.7
65.7 ± 26.1 8.7 12.4 ± 0.8 1.8
BM
15.6 ± 4.4 60.6 25.1 ± 14.5 13.4
47.3 ± 8.7 84.8 128.6 ± 28.8 86.5
PLLAgNPs
UW
7.4 ± 1.3 96.2 8.9 ± 1.7 2.9
55.7 ± 13.4 3.7 115.7 ± 15.4 88.1
BM
686.6 ± 133.8 95.0 542.4 ± 135.7 97.1
5289 ± 214 4.7 5038 ± 105 2.8
CTAAgNPs
UW
17.4 ± 5.4 88.1 22.3 ± 5.7 6.0
81.5 ± 7.6 2.9 — —
193.6 ± 36.8 8.7 182.9 ± 17.4 91.6
BM
27.9 ± 5.4 40.9 32.3 ± 6.7 4.2
71.8 ± 7.1 10.6 — —
602.0 ± 57.2 51.4 418.8 ± 72.7 95.6
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Table 2: Hydrodynamic diameter (dH) obtained from size distributions by volume and intensity of uncoated superparamagnetic iron oxide nanoparti-
cles (UNSPIONs) and coated with poly(L-lysine) (PLLSPIONNs) or D-mannose (MANSPION) in ultrapure water (UW) and biological medium (BM)
after 1 h at 25 °C.
NPs type medium dH (nm) % mean volume dH (nm) % mean intensity
UNSPIONs
UW
62.0 ± 13.8 77.1 48.9 ± 19.4 82.3
105.6 ± 28.8 22.3 130.3 ± 30.0 17.1
BM
765.7 ± 170.4 95.1 670.7 ± 200.1 92.5
5380.5 ± 72.3 4.6 5060.2 ± 899.9 6.8
PLLSPIONs
UW
50.7 ± 24.2 37.7 53.6 ± 23.4 44.8
279.7 ± 144.2 61.6 254.8 ± 112.4 54.9
BM
138.8 ± 35.1 16.3 153.3 ± 42.2 35.7
688.6 ± 167.3 76.7 610.4 ± 185.6 61.3
MANSPIONs
UW 43.8 ± 20.9 85.8 70.9 ± 39.3 97.6
130.3 ± 30.1 15.9 — —
BM
131.6 ± 29.7 1.6 137.6 ± 29.3 5.3
723.0 ± 170.6 93.7 636.2 ± 193.6 93.7
5322.4 ± 198.3 4.8 5209.7 ± 192.1 1.0
maximums. In terms of size, the majority of AgNPs had a dH
that ranged from 5 to 25 nm. As expected, the intensity-based
size distributions yielded different results than the volume-
based values. For example, a volume of more than 95% of
PLLAgNPs had a mean size of 7.4 ± 1.3 nm, while intensity-
weighted distribution showed a mean value of 115.7 ± 15.4 for
ca. 88.1% of PLLAgNPs (Table 1). As already noted, it is
known that intensity size distributions are subject to scattering
interferences because the intensity of scatter light is much
greater for large agglomerates compared to small particles. In
accordance with the obtained DLS data, TEM images in UW
showed monodisperse AOTAgNPs, PVPAgNPs, TweenAgNPs
and PLLAgNPs, whereas other AgNPs were polydispersed
(Figure 2). All of the AgNPs visualized by the TEM were
spherically shaped except rod-like CITAgNPs (Figure 2).
The DLS measurements showed that SPIONs had two particle
populations in UW: one with dH of about 50 nm and another
with dH larger than 100 nm at peak maximum (Table 2). The
initially synthesized SPIONs were much smaller than 10 nm as
observed by TEM [4,47]. The results presented in Table 2 and
Figure 3 clearly indicate a formation of SPION aggregates in
UW. As it has been documented that SPIONs lose colloidal
stability over time [47], the aggregates were expected consid-
ering that the SPIONs were synthesized 40–60 days prior to
DLS and TEM experiments.
The ELS data, presented in Figure 4, showed that nine out of
the eleven studied NPs had negative ζ-potential in UW, al-
Figure 2: Transmission electron micrographs (TEM) of different silver
nanoparticles coated with trisodium citrate (CITAgNP), sodium bis(2-
ethylhexyl) sulfosuccinate (AOTAgNP), poly(vinylpyrrolidone)
(PVPAgNP), Brij 35 (BrijAgNP), Tween 20 (TweenAgNP), bovine
serum albumin (BSAAgNP), poly(L-lysine) (PLLAgNP), and
cetyltrimethylammonium bromide (CTAAgNP). Scale bars are 100 nm.
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Figure 3: Transmission electron micrographs (TEM) of differently
coated superparamagnetic iron oxide nanoparticles: uncoated
(UNSPION) and coated with D-mannose (MANSPION) and poly(L-
lysine) (PLLSPION). Scale bars are 100 nm.
though one of our “synthetic” goals was to prepare positively,
neutral and negatively coated, i.e., charged metallic NPs
(Figure 1). The coating of AgNPs with PLL and CTA led to
positively charged AgNPs characterized by ζ-potentials of
23.6 ± 4.0 and 38.5 ± 2.9 mV, respectively. Both of these
coating agents are positively charged at pH 6–7, which was
used in this study. For PLLSPIONs, the negatively charged sur-
face of the maghemite core was only partially compensated by
positive PLL resulting in a ζ-potential value of −5.4 ± 0.4 mV.
As expected, the use of negatively charged coating agents CIT,
AOT and MAN resulted in NPs bearing an overall negative
charge of −38.5 ± 2.9, −27.8 ± 1.9 and −26.9 ± 1.1 mV, respec-
tively. For AgNPs coated with uncharged molecules; PVP,
Tween 20 and Brij 35, we expected a ζ-potential close to zero.
However, all of the three mentioned AgNPs were characterized
by slightly negative ζ-potentials ranging from −6 to −19 mV.
Since we employed a borohydride reduction of AgNO3 during
AgNP synthesis, the  anions left over after synthesis were
obviously attached next to the surface coatings of PVPAgNPs,
BrijAgNPs and TweenAgNPs and led to a slightly negative
ζ-potential. Synthesis of AgNPs using BSA as coating agent
also resulted in NPs with a slightly negative surface charge.
Figure 4: Zeta-potential (ζ) values of differently coated silver (AgNPs)
and superparamagnetic iron oxide nanoparticles (SPIONs) in ultra-
pure water (UW), biological medium (BM) and biological medium
supplemented with 0.1% bovine serum albumin (BMP) after 1 h at
25 °C. Coating agents: trisodium citrate (CIT), sodium bis(2-ethylhexyl)
sulfosuccinate (AOT), poly(vinylpyrrolidone) (PVP), Brij 35 (Brij),
Tween 20 (Tween), bovine serum albumin (BSA), poly(L-lysine) (PLL),
cetyltrimethylammonium bromide (CTA) and D-mannose (MAN).
Agglomeration behavior of different AgNPs
and SPIONs in biological media
The DLS and ELS methods were used to quantify the agglomer-
ation of differently coated AgNPs and SPIONs in DMEM, a
model biological media (BM), while TEM provided a visual
presentation of NPs. Although the terms aggregation and
agglomeration are used interchangeably, this study uses the
term agglomeration because many recent studies have shown
that NPs tend to agglomerate in aqueous biological matrices
characterized by high ionic strength and neutral pH, such as
phosphate-buffered saline and cell culture media [19-26,30].
The term aggregation indicates strongly bonded or fused parti-
cles and agglomeration indicates more weakly bonded particles.
All of the obtained results for the agglomeration of differently
coated AgNPs and SPIONs in BM are given in Table 1 and
Figures 4–6. One would have expected that the stabilization
Beilstein J. Nanotechnol. 2016, 7, 246–262.
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Figure 5: Temporal evolution of the hydrodynamic diameter (dH) obtained from size distributions by volume of differently coated metallic nanoparti-
cles in biological media (BM) and biological media supplemented with 0.1% bovine serum albumin (BMP) over a period of 1 h at 25 °C. Results are
presented for silver nanoparticles coated with trisodium citrate (CITAgNP), sodium bis(2-ethylhexyl) sulfosuccinate (AOTAgNP), poly(vinylpyrrolidone)
(PVPAgNP), Brij 35 (BrijAgNP), poly(L-lysine) (PLLAgNP), cetyltrimethylammonium bromide (CTAAgNP); and superparamagnetic iron oxide nanopar-
ticles uncoated (UNSPION) and coated with D-mannose (MANSPIONs) and poly(L-lysine) (PLLSPION).
would have been more effective using ionic coating agents
when compared to non-ionic surfactants and polymers, but the
explanation for the agglomeration behavior of the investigated
AgNPs and SPIONs is not as straightforward. For CITAgNPs,
PVPAgNPs and BSAAgNPs, the results clearly showed good
colloidal stability, i.e., the size distributions in BM were similar
to those obtained for dispersions in UW (Table 1).
However, the absolute value of the ζ-potential for BSAAgNPs
increased after dispersion in BM. Conversely, the ζ-potential for
CITAgNPs and PVPAgNPs decreased compared to that
measured in UW (Figure 4). It would be expected that, when
the ζ-potential approaches zero, interparticle repulsion
decreases as does the stability of the dispersion. CITAgNPs are
stabilized primarily through electrostatic repulsions, while
bulky ligands such as PVP and BSA provide additional steric
hindrances. Our results, in accordance with previously
published data [48], imply that CIT, PVP and BSA provided
colloidal stability for AgNPs irrespective to the type of surface
interactions. It is interesting that we have recently observed [49]
a significant agglomeration of CITAgNPs in phenol red-free
DMEM (product number 12-709, Lonza, Verviers, Belgium)
and in RPMI-1640 medium (product number R5886, Sigma-
Aldrich, Munich, Germany) [50]. Both of these formulations
contained HEPES as the buffering agent, while the media used
in the recent work, where much like in this study no agglomera-
tion of CITAgNPs [48] was observed, were buffered with phos-
phate buffer (PB). The most common buffering agents are PB
and HEPES, which significantly differ in their chemical compo-
sition. Consequently, the behavior and stability of NPs in PB
might be completely different from that in HEPES buffering
system [21]. As phosphate, and not HEPES, is a normal
constituent of mammalian blood and other body fluids, DMEM
buffered with PB was chosen as the model BM.
Other AgNPs and all of the SPIONs agglomerated almost
immediately after addition to the media, as can be seen from
Figure 5. Thus, the high ionic strength of BM caused an
agglomeration expected to be close to diffusion-limited. More-
over, the fast agglomeration of investigated NPs in BM was
visible even to the naked eye. Immediately after the addition of
clear NP stock solution into the BM, a cloudy black precipitate
Beilstein J. Nanotechnol. 2016, 7, 246–262.
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Figure 6: Transmission electron micrographs (TEM) and corresponding size distributions by volume of differently coated metallic nanoparticles in bio-
logical media after 1 h at 25 °C. Results are presented for silver nanoparticles coated with trisodium citrate (CITAgNP), sodium bis(2-ethylhexyl) sulfo-
succinate (AOTAgNP), Brij 35 (BrijAgNPs), bovine serum albumin (BSAAgNPs), poly(L-lysine) (PLLAgNP), cetyltrimethylammonium bromide
(CTAAgNP), and poly(vinylpyrrolidone) (PVPAgNP) and superparamagnetic iron oxide nanoparticles uncoated (UNSPION) and coated with poly(L-
lysine) (PLLSPION). Scale bars are 100 nm.
was observed at the bottom of the flask. AOTAgNPs,
BrijAgNPs, PLLAgNPs, UNSPIONs and MANSPIONs showed
the most pronounced agglomeration in BM and clusters of ca.
5 µm were observed (Table 1, Figure 6). As can be seen from
the TEM micrographs and corresponding size distributions
(Figure 6), agglomerated NPs are characterized by very high
polydispersity. The CTAB and Tween coatings prevented
severe agglomeration of AgNPs in BM due to steric repulsion
effects. According to the volume-weighted size distribution
data, less than 10% of TweenAgNPs population agglomerated
in BM, while 50% of CTAAgNPs was agglomerated to clusters
of about 600 nm (Table 1). Interestingly, PLL prevented a harsh
agglomeration of SPIONs, but not of the AgNPs. It is known
that NP coating agents can lose their stabilizing effect at high
ionic strength due to complexation with counter ions. Conse-
quently, van der Waals attraction forces induce aggregation of
unprotected NPs [3]. Thus, the chemical nature of the surface-
capping agents played a significant role in the conservation of
colloidal stability of metallic NPs in BM. The observed differ-
ences in ζ-potential in BM compared to UW provide an addi-
tional important explanation [21]. Dispersion in BM resulted in
a net-negatively-charged layer on the surfaces of all of the
studied NPs, while absolute values of the ζ-potential were de-
creased in BM for all NPs except for BrijAgNPs, TweenAgNPs,
BSAAgNPs and PLLSPIONs. This observation may explain the
good colloidal stability of BSAAgNPs and PLLSPIONs in BM,
moderate stability of TweenAgNPs, and instability of
PLLAgNPs, but is contradictory to the observed behavior of
BrijAgNPs. The electrostatic stabilization effect, playing the
key role for CITAgNPs was also important for PVPAgNPs
characterized by the negative ζ-potential imparted by adsorbed
, a residual side product from AgNPs synthesis. In addi-
tion, PVPAgNPs were stabilized by steric repulsion of PVP
molecules. However,  anions were also attached to the
BrijAgNPs and TweenAgNPs coatings, but adsorption of
Tween 20 and Brij 35 surfactants to the AgNPs surfaces was
much weaker, thus providing lower colloidal stability com-
pared to PVP. This has already been described previously [51].
It is important to note that charge reversal was noticed in the
ζ-potential measurements of positively charged PLLAgNPs and
CTAAgNP after dispersion in BM, which affected their stability
and heavily increased the possibility of their agglomeration.
Lower stability of PLLAgNPs compared to CTAAgNPs could
be explained by the much more negative ζ-potential value of
Beilstein J. Nanotechnol. 2016, 7, 246–262.
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Table 3: Hydrodynamic diameter (dH) obtained from size distributions by volume and intensity of differently coated silver (AgNPs) and superpara-
magnetic iron oxide nanoparticles (SPIONs) in biological medium supplemented with 0.1% bovine serum albumin (BMP) after 1 h at 25 °C. Coating
agents: trisodium citrate (CIT), sodium bis(2-ethylhexyl) sulfosuccinate (AOT), poly(vinylpyrrolidone) (PVP), Brij 35 (Brij), Tween 20 (Tween), bovine
serum albumin (BSA), poly(L-lysine) (PLL), cetyltrimethylammonium bromide (CTA) and D-mannose (MAN).
NPs type dH (nm) % mean vol dH (nm) % mean intensity
CITAgNPs
114.2 ± 12.9 82.3 117.8 ± 9.5 99.9
22.4 ± 2.9 17.7 — —
AOTAgNPs
47.8 ± 8.9 1.7 63.4 ± 27.0 7.1
671.0 ± 140.4 0.1 548.9 ± 126.4 20.4
PVPAgNPs 59.6 ± 11.4 0.2 82.9 ± 20.7 36.2
BrijAgNPs
59.2 ± 9.4 2.7 91.7 ± 14.0 74.6
848.3 ± 9.6 0.3 — —
4304 ± 204 0.3 4882 ± 187 8.9
TweenAgNPs 55.2 ± 6.8 0.9 87.8 ± 10.9 70.4
BSAAgNPs 86.5 ± 17.5 0.2 124.6 ± 26.7 41.4
PLLAgNPs
85.6 ± 17.6 41.2 34.3 ± 7.8 2.3
208.4 ± 14.8 56.7 174.9 ± 8.4 97.7
CTAAgNPs 71.8 ± 6.4 0.9 99.7 ± 10.6 72.5
UNSPIONs
43.1 ± 6.4 0.1 54.7 ± 19.4 4.3
417.6 ± 41.7 0.1 489.8 ± 69.7 29.7
PLLSPIONs 537.9 ± 64.3 0.3 382.1 ± 28.5 69.8
MANSPIONs
30.5 ± 15.9 0.1 31.8 ± 14.8 3.1
778.1 ± 179.7 0.3 680.4 ± 237.7 41.3
CTAAgNPs in BM. The DLS results agree well with the com-
plementary information obtained by TEM observation
(Figure 6). The TEM images provide evidence that no changes
in the morphology or size of the CITAgNPs, PVPAgNPs and
BSAAgNPs occurred upon dispersion in BM. Conversely, after
being dispersed in the BM, all of the other studied NPs exhib-
ited disordered and agglomerated morphologies (Figure 6).
Small AgNP nanospheres coated with AOT, Brij, Tween, PLL
and CTAB, and SPIONs were strongly damaged and had irregu-
lar surfaces (Figure 6).
In summary, different coating agents used on AgNPs and
SPIONs imparted different colloidal stabilities in the same bio-
logical media. The obtained data clearly show that a combina-
tion of negative charge and high adsorption strength of coating
agents alongside molecular structure are important factors that
impart good colloidal stability of metallic NPs in electrolyte-
rich fluids. Moreover, DLS, ELS and TEM proved to be suffi-
cient and fast screening methods for a colloidal stability evalua-
tion of metallic NPs in biological environments.
Effect of albumin on the dispersibility of
AgNPs and SPIONs in biological media
When suspended in biological fluids, NPs rapidly interact with
proteins that form a dynamical layer all over the NP surface,
known as a protein corona (PC) [36,37,39]. Subsequently, the
formation of PC modifies the physicochemical properties of
NPs, while proteins may undergo conformational and func-
tional changes [52-56]. Consequently, the presence of proteins
in dispersion media alters the physicochemical behavior and
stability of NPs. DLS data, shown in Table 3 and Figure 5,
suggest that BSA stabilized the dispersion of both types of
studied metallic NPs in BMP.
A similar stabilizing effect of BSA against the aggregation of
nanoparticles was previously reported [3,5,30,57,58]. Although
the presence of BSA prevents NP agglomeration, the dH ob-
tained from size distributions by volume increased by a factor
of two and more for all NPs upon suspension in BMP due to the
bulky globular nature of the BSA coating. This can be seen by
comparing data from Table 1, Table 2 and Table 3. The very
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heterogeneous size distribution for different NPs indicates non-
uniform surface coverage depending on surface coating. Thus,
the BSA molecules clustered and adsorbed on the NP surface
variously for different AgNPs and SPIONs, resulting in a thick-
ness variation. Moreover, the BSA coating is likely to include
many surface regions that retain adsorbed coating agents,
remaining from the original synthesis. For CITAgNPs,
PVPAgNPs, TweenAgNPs, BSAAgNPs and PLLSPIONs, char-
acterized by a bimodal size distribution in UW, interaction with
BSA led to a monomodal size distribution in which all NPs
were covered by several BSA molecules. For the NPs that were
agglomerated in BM, the addition of BSA inhibited completely
or significantly reduced the agglomeration process. It is clearly
visible from Figure 5 that the dH obtained from size distribu-
tions by volume was constant and significantly lower in BMP
compared to BM for AOTAgNBPs, BrijAgNPs, PLLAgNPs,
and CTAAgNPs after 1 h. The observed increase in the mean
dH for CITAgNPs, UNSPIONs, MANSPIONs and PLLS-
PIONs in the BMP after 1 h is not a result of agglomeration, but
rather an indication of a slower adsorption of BSA molecules to
NP surfaces depending on the interchange of the coating agent
with BSA. Such an assumption was further confirmed by TEM
that clearly showed non-agglomerated, well-dispersed NPs in
the BMP (Figure 7). This highlights the difficulties of using the
DLS technique for extracting changes in the actual size of NP
core when taking into account surface coatings, which can
agglomerate/cluster on the NP surface. BSA may be bound by a
relatively strong covalent bond between the NPs surface and
cysteine groups or via protein–protein electrostatic or depletion
interactions. If both interactions take place simultaneously, the
thickness of a PC will vary depending on the type of NP.
The ELS data showed that all of the NPs had very similar
potential values in BMP regardless of the coating agent, ranging
from −9.9 to −12.4 mV (Figure 4). The decrease of absolute
values of the ζ-potential toward zero in the BMP compared to
BM imply that the BSA coating itself was the main source of
particle stability in the BMP, as this protein is just slightly nega-
tively charged at physiological pH values. The measured
ζ-potentials were very close to the values determined for pure
BSA dispersions, −7.5 ± 0.04 mV, which is not surprising
taking into account the relatively high protein concentration.
Thus, BSA conjugates provided an enhanced electrostatic repul-
sion against the agglomeration of metallic NPs in DMEM. The
BSA has negative charges above its isoelectric point (pH 4.78)
[59] and the electrostatic forces dominate over hydrophobic
interactions. Accordingly, the attractive forces between the pos-
itively charged AgNPs and the negatively charged BSA led to
protein adsorption, but questions remained about why the repul-
sive forces between the negatively charged NPs and BSA did
not prevent protein adsorption. Besides a negatively charged
Figure 7: Transmission electron micrographs (TEM) of different silver
nanoparticles coated with trisodium citrate (CITAgNP), sodium bis(2-
ethylhexyl) sulfosuccinate (AOTAgNP), poly(vinylpyrrolidone)
(PVPAgNP), Brij 35 (BrijAgNP), Tween 20 (TweenAgNP), bovine
serum albumin (BSAAgNP), poly(L-lysine) (PLLAgNP), and cetyltri-
methylammonium bromide (CTAAgNP) in biological media supple-
mented with 0.1% bovine serum albumin (BMP) after 1 h. Scale bars
are 100 nm.
surface at physiological pH, the structure of BSA is also charac-
terized by positively charged lysine and cysteine [60]. There-
fore, its interaction with NPs is hardly trivial.
The most important observation of this study is that BSA
enables a colloidal stabilization of metallic NPs in biological
fluids regardless of their chemical composition, surface struc-
ture and surface charge. This is also evident from the micro-
graphs typically visualized by TEM for NPs dispersed in BMP
(Figure 7). These images show that NPs are well-dispersed, but
can be found only on grid areas where drops of BMP settled.
Only BSAAgNPs and BrijAgNPs were dispersed all over the
TEM grid.
Our results are in good agreement with recently published data
for stabilization of different metallic NPs in protein-containing
media [3,54,61-64]. The mechanisms of PC adsorption and the
way how the PC is arranged at the NP surface are crucial for
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Table 4: Summarized effects of different coating agents on the stability of silver and maghemite nanoparticles in model biological medium after 1 h.
UW - ultrapure water, BM - biological cell culture medium without addition of protein, BMP - BM supplemented with common serum protein.
coating agent BM compared with UW BMP compared with BM
trisodium citrate (CIT)
stable dispersion,
│ζ│ decreased,
no morphology changes
stable dispersion,
│ζ│ decreased,
localized in BMP areas on TEM grid
sodium bis(2-ethylhexyl)
sulfosuccinate (AOT)
pronounced aggregation,
│ζ│ decreased,
morphology changes (irregular shapes)
stable dispersion,
│ζ│ decreased,
localized in BMP areas
cetyltrimethylammonium
bromide (CTA)
partial stabilization,
│ζ│ decreased, charge reversal,
morphology changes (irregular shapes)
stable dispersion,
│ζ│ decreased,
localized in BMP areas on TEM grid
Brij 35 (Brij)
pronounced aggregation,
│ζ│ increased,
morphology changes (irregular shapes)
stable dispersion,
│ζ│ decreased,
dispersed over the TEM grid
Tween 20 (Tween)
partial stabilization,
│ζ│ increased,
morphology changes (irregular shapes)
stable dispersion,
│ζ│ decreased,
localized in BMP areas on TEM grid
poly(vinylpyrrolidone)
(PVP)
stable dispersion,
│ζ│ decreased,
no morphology changes
stable dispersion,
│ζ│ decreased,
localized in BMP areas on TEM grid
poly(L-lysine) (PLL)
pronounced aggregation for AgNPs,
│ζ│ decreased, charge reversal,
partial stabilization for SPIONs,
│ζ│ increased,
morphology changes (irregular shapes)
stable dispersion,
│ζ│ increased,
localized in BMP areas on TEM grid
bovine serum albumin
(BSA)
stable dispersion,
│ζ│ increased,
no morphology changes
stable dispersion,
│ζ│ decreased,
dispersed over the TEM grid
D-mannose (MAN)
pronounced aggregation,
│ζ│ decreased,
morphology changes (irregular shapes)
stable dispersion
│ζ│ decreased
localized in BMP areas on TEM grid
gaining an understanding of the biological reactivity of NPs in
vivo [61]. In principle, the protection against colloidal agglom-
eration offered by BSA could be used in different nanotechno-
logical applications, but also highlights the facilitated transport
of nanoparticles across the bloodstream. This study clearly
shows that surface coating strongly affects colloidal stability
and behavior of metallic NPs in biological environment as
presented in Table 4.
Behavior of NPs in blood and blood plasma
The implications of the PC on the bioactivity nanomaterials in
vivo are enormous. Biological fluids are complex environments
in which it is difficult even to predict all of the possible NP
modifications and interactions. In such an environment, the
dynamic adsorption of different biomolecules onto the surface
of metallic NPs is a well-established fact, which irreversibly
changes the nature of the original NPs [61,65].
In order to examine how differently coated metallic NPs be-
have in more complex biological fluids, PVPAgNPs,
BSAAgNPs, AOTAgNPs and PLLAgNPs were dispersed in rat
whole blood (WhBl) and blood plasma (BlPl). After incubation
for 1 h, samples were examined by TEM as described in the
Experimental section. The TEM micrographs showed rather
unexpected features (Figure 8). All of the AgNPs except
PVPAgNPs, which were initially small and exhibited spherical
shape, were transformed depending on the media. AOTAgNPs
and BSAAgNPs significantly changed their shape and size in
WhBl, but stayed very well dispersed in BlPl. On the contrary,
the morphology of PLLAgNPs and PVPAgNPs changed in
BlPl, but remained unchanged in WhBl (Figure 8). The
BSAAgNPs formed square- and rectangular-shaped agglomer-
ates larger than 200 nm in WhBl. Similarly shaped structures
were found for PLLAgNPs in BlPl, while PVPAgNPs formed
large hexagonal nanocomposites in BlPl (Figure 8). Interest-
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Figure 8: Transmission electron micrographs (TEM) of different silver nanoparticles coated with sodium bis(2-ethylhexyl) sulfosuccinate (AOTAgNP),
bovine serum albumin (BSAAgNP), poly(L-lysine) (PLLAgNP), and poly(vinylpyrrolidone) (PVPAgNP) in whole blood (WhBl) and blood plasma (BlPl)
of Wistar rats after 1 h.
ingly, AOTAgNPs were associated in triangle clusters formed
of small, separated NPs (Figure 8).
It has been very well established that the shape of metallic NPs
may be controlled using different surfactants [66,67]. The
choice and addition of surfactants may successfully control the
synthesis of nanodiscs, triangular nanoplates or nanospheres. In
recent years, solution-phase methods developed rapidly toward
a reproducible preparation of metallic NPs with controlled
shape [66]. A typical synthesis of nanocrystals can be divided
into three levels: nucleation, evolution of nuclei into seed, and
growth of seed into nanocrystals. The mechanism behind such a
synthesis is extremely complicated, but the type of coating
agent proved to be crucial for the final shape of a nanocrystal
[66]. The micrographs presented in Figure 8 suggest that our
initially small AgNPs appeared as seeds in WhBl or BlPl, where
further growth to nanocomposites was accomplished. Thus, our
results indicate an in vivo synthesis of metallic nanocrystals in
mammalian organisms, similarly to that already described in
microorganisms [68].
There are many examples of in vivo formation of nanomateri-
als (NMs) in biological systems [68]. The most common
process is the biomineralization of bones and shells [69]. It is
interesting that the shape of these bionanomaterials is usually
induced by an engulfing organic matrix [69]. Different microor-
ganisms, such as magnetotactic bacteria or diatoms, are also
able to produce nanocrystals in vivo [70-74]. The biosynthesis
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of metallic NMs with controlled morphology is governed by
using different bacterial strains [68]. For example, Pseudomo-
nas stutzeri AG259, a metal-accumulating bacterium, is able to
synthesize AgNPs through its detoxification process after expo-
sure to silver [75]. It is somewhat intriguing that we observed
similar AgNPs forms in WhBl and BlPl (Figure 8) as already
described for Pseudomonas stutzeri AG259 [75].
The reason for the observed differences between WhBl and
BlPl is unclear, but it implies that NP stability and morphology
can be significantly changed with only small changes in the
composition of the biological medium. Our results point out that
an accurate characterization of physicochemical parameters and
behavior of NPs in a particular biological environment is imper-
ative for clinical relevance to target organ groups. As a conse-
quence, the development of nanomaterials for theragnostics is
an ambitious goal with many parameters to assess.
Conclusion
The lack of fundamental knowledge about the biocompatibility
of metal-based nanomaterials and their effect and behavior in
biological systems may restrict the capability to establish princi-
ples used as regulatory guidance and design safe nanomaterials.
The detection and assessment of the colloidal stability of
metallic NPs is vital. The presented work describes a systemati-
cally conducted experimental approach consisting of tech-
niques that, although simple, are sufficient to perform a fast
screening of the biocompatibility and colloidal stability of
metallic NPs in biological environments. The obtained results
have shown that the agglomeration behavior of metallic NPs in
aqueous solutions with the pH and ionic strength close to bio-
logical fluids depends on the surface coating. This study con-
firmed that the presence of proteins such as BSA plays a major
role in the colloidal stabilization of metallic NPs in biological
fluids. Data on the behavior of differently coated NPs in whole
blood and blood plasma highlights the importance of investigat-
ing the behavior and effects of metallic NPs in a variety of bio-
logical fluids in addition to including as many of the NPs prop-
erties as possible. It is not superfluous to stress that a system-
atic study of the stability and behavior for various NPs in addi-
tion to the best possible characterization of NPs would enable
clear conclusions and predictions about the effects of NPs in a
variety of biological systems.
Experimental
Chemicals and materials
If not otherwise stated, chemicals were obtained from Sigma-
Aldrich Chemie GmbH (Munich, Germany). Dulbecco’s modi-
fied Eagle’s medium (DMEM) with 4.5 g·L−1 glucose without
L-glutamine and sodium dihydrogen phosphate as buffering
agent (product number 12-614Q) was obtained from Lonza
(Verviers, Belgium). Bovine serum albumin (product number
A-7906, Sigma-Aldrich Chemie GmbH, Steinheim, Germany)
was used as received without further purification. The plastic
and glassware used for chemical analysis were from Sarstedt
(Belgium). Osmium tetroxide was purchased from Agar Scien-
tific (Stansted, UK) and TAAB epoxy resin (medium hard)
from Aldermaston (Berkshire, UK). All dilutions were made
with ultrapure water (18.2 MΩ·cm), obtained from a
GenPureUltraPure water system (TKA Wasseraufbereitungssys-
teme GmbH, Niederelbert, Germany).
Synthesis of metallic nanoparticles
The syntheses of AgNPs and SPIONs with different surface
coatings were conducted as previously described [49] using
structurally diverse surface coatings: trisodium citrate (CIT), so-
dium bis(2-ethylhexyl) sulfosuccinate (AOT), cetyltrimethyl-
ammonium bromide (CTA), poly(vinylpyrrolidone) (PVP),
poly(L-lysine) (PLL), bovine serum albumin (BSA), Brij 35
(Brij), Tween 20 (Tween) and D-mannose (MAN).
Silver nanoparticles coated with sodium bis(2-ethylhexyl) sulfo-
succinate (AOTAgNP), cetyltrimethylammonium bromide
(CTAAgNP), poly(vinylpyrrolidone) (PVPAgNP), poly(L-
lysine)(PLLAgNP), and Tween 20 (TweenAgNP) were synthe-
sized by reducing AgNO3 with NaBH4. Briefly, the solutions of
capping agent were prepared by dissolving appropriate amounts
of capping agent in ultra-pure water. Then, 9.2 mL of 50 mM
AgNO3 was added dropwise and dissolved by constant stirring
on an IKA RCT basic magnetic stirrer plate (IKA Werke,
Germany). To this solution, a volume of 2 mL of 0.4 M NaBH4
solution was added dropwise (about 1 drop/s). The final concen-
trations of AOT, CTAB, PVP, PLL, and Tween were 500, 500,
75, 20 and 6 mM, respectively. The reaction mixture was stirred
vigorously at room temperature for 45 min. After the synthesis,
silver colloids were centrifuged at 11,000g for 20 min. After
decanting the supernatant, the residue was suspended in ultra-
pure water and kept at 4 °C in the dark. BrijAgNPs were syn-
thesized by mixing an aqueous solution of AgNO3 (0.09 mL,
50 mM), Brij 35 (5 mL, 0.45 mM) and hydrogen peroxide
(0.105 mL, 30 wt %) with 44.5 mL ultrapure water. The mix-
ture was vigorously stirred at room temperature in the presence
of air. The final volume was kept at 50 mL. To this mixture,
NaBH4 (0.4 mL, 200 mM) was rapidly injected, generating a
colloid that was pale yellow. After 30 min, the colloid dark-
ened to a deep-yellow color indicating the formation of AgNPs.
CITAgNPs were synthesized via the following protocol: 200 μL
of the aqueous solution of ascorbic acid (AsA) with a concen-
tration of 0.1 mM was added into 190 mL of boiling water, fol-
lowed by boiling for an additional 1 min. Then, 3.8 mL of the
aqueous solution of sodium citrate (35.4 mM) and 1.2 mL of the
aqueous solution of AgNO3 (50 mM) were consecutively added
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to 5 mL of water under stirring at room temperature. After
5 min of incubation at room temperature, the citrate–AgNP
mixture solution was injected into the boiling aqueous solu-
tions of AsA (just after 1 min boiling after AsA addition to
boiling water). The final concentrations of reactants were
0.673 mM for sodium citrate, 0.3 mM for AgNO3 and 0.1 μM
for AsA. The color of the reaction solution quickly changed
from colorless to yellow. The transparent and yellow reaction
solution was further boiled for 1 h under stirring to warrant for-
mation of uniform quasi-spherical AgNPs. Purification of
AgNPs was performed by centrifugation of colloidal solution
two times at 11,000g for 30 min. Supernatant was decanted and
precipitate was redispersed in ultrapure water by sonification.
Silver nanoparticles directly conjugated to bovine serum
albumin (BSAAgNPs) were prepared as follows: 7.6 mL of
50 mM AgNO3 was added dropwise under stirring to 33 mL of
ultrapure water containing dissolved 90 mg of BSA. Then, sodi-
um borohydride (1 mL, 0.397 M) was added to an aqueous
solution of AgNO3 and BSA under vigorous stirring. The molar
ratio of Ag+:BSA and  were 28:1 and 1:1, respective-
ly. The reaction volume was 40 mL, and contained 13.50 μmol
BSA. The reaction was allowed to proceed for 1 h, and the
product was purified by precipitation at −5 °C using ultracen-
trifugation.
Three different maghemite nanoparticles (γ-Fe2O3NPs),
uncoated, coated with poly(L-lysine) and D-mannose, were pre-
pared by coprecipitation of FeCl2 and FeCl3 using ammonium
hydroxide, followed by the oxidation of the resulting magnetite
with sodium hypochlorite [46,47]. The obtained superpara-
magnetic maghemite (γ-Fe203) was referred as uncoated
γ-Fe2O3NPs (UNSPIONs). The post-synthesis coating of
maghemite with D-mannose (MANSPIONs) or poly(L-lysine)
(PLLSPIONs) was achieved [46] by addition of D-mannose or
poly(L-lysine) to the primary uncoated maghemite cores [4].
Analytical methods
As described in [49], the size and charge of NPs were measured
by dynamic (DLS) and electrophoretic light scattering (ELS),
respectively, using Zetasizer Nano ZS (Malvern, UK). Visuali-
zation of NPs were done using a transmission electron micro-
scope (TEM, Zeiss 902A). Total silver concentrations in AgNPs
were determined using an Agilent Technologies 7500cx induc-
tively coupled plasma mass spectrometer (ICPMS) (Waldbronn,
Germany).
Characterization of nanoparticles and
dispersion protocols
Careful characterization and colloidal stability evaluation of
each NP type was conducted using several different dispersion
protocols: ultrapure water (UW), DMEM high glucose as model
biological medium (BM), BM supplemented with 0.1 or 1%
BSA (BMP), whole blood (WhBl) and blood plasma (BlPl)
taken from the Wistar rat. The aim was to investigate the behav-
ior of each NP after 1 h in different biological environments. In
each dispersion experiment, NPs were applied at total metal
concentration of 1 or 10 mg·L−1.
The stock solution of BSA in DMEM was freshly prepared for
each experiment and then diluted to the desired concentrations.
Differently coated metallic NPs were dispersed in BSA solu-
tions to the final concentration of 1 mg·L−1 just before DLS
measurements. Among the most important parameters of
colloidal systems is their particle size, which can be used as an
indicator of their stability. DLS is the most common and versa-
tile technique for measuring size distribution of NPs in solu-
tions (Murdock et al. [53]). However, conventional DLS has its
limitations. The main interferences in the biological matrix
originate from the light scattering of different biological compo-
nents and a mixture of different sizes of fractal-shaped agglom-
erates. In our model BMP system, the effect of BSA scattering
requires cautious and thoughtful analysis of DLS results. The
pure BSA in DMEM had a volume-weighted mean size of
7.4 ± 0.8 nm, while dH obtained from size distributions by in-
tensity was shown to be 9.6 ± 0.9 nm, as expected for a glob-
ular protein of 66 kDa [60]. Thus, the BSA scattering is the
most significant in interpretation of DLS results for small, non-
agglomerated NPs with sizes close to BSA. That was not the
issue in the present study. The size of the measured metallic
NPs in all BMP systems was at least two-fold larger than dH of
BSA therefore no overlaps of the peak maximums were ob-
served. On the other hand, due to the low concentration of
metallic NP, the volume peak area (%) in all of the BMP
systems was significantly smaller compared to BSA. Converse-
ly, size distribution by intensity showed more realistic peak
ratios. To address this problem to some extent, BSA levels 2.4
(1% BSA) and 24 (0.1% BSA) times lower than physiological
concentrations ([BSA] = 375 μM) were added to the BM (in
order to prepare BMPs). In order to present results in a trans-
parent way and obtain accurate conclusions from the DLS mea-
surements, size distribution by intensity and volume were used
in analyzing the results. Intensity-weighted size distribution is
the first order result from a DLS experiment calculated from the
scatter intensity of each particle in solution. On the other hand,
intensity distributions can be biased towards larger particles
since the intensity of particle light scatter varies with the 6th
power of particle diameter. In order to avoid overestimations
arising from the scattering of larger particles, volume-weighted
size distributions are often used. In addition, dH obtained from
size distributions by volume was presented so results could be
comparable with our previously published studies. It should be
noted that the data was sometimes compiled from different syn-
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thesis batches of NPs, leading to some discrepancy in the size
distributions of the various control samples.
For dispersions of NPs in whole blood (WhBl) and blood
plasma (BlPl), whole blood and blood plasma were obtained
from healthy twelve weeks old male Wistar rats. Animals were
killed by narketan/xilapan anesthesia following the whole blood
collection by cardiac puncture. The experiment was approved
by the Ethics Committee for Animal Studies of the Institute for
Medical Research and Occupational Health according to Euro-
pean and Croatian legislation on animal experimentation and
International Council for Laboratory Animal Science ethical
guidelines for researchers, respectively. Then, different NPs
were dispersed in 1 mL of WhBl or BlPl at a final metal con-
centration of 10 mg·L−1 and agitated for 1 h on a digital waving
rotator (Thermo Scientific, USA). After incubation, suspen-
sions were diluted 50 times before further analysis. It should be
noted that DLS and ELS measurements were impossible in
WhBl and BlPl suspensions.
TEM samples were prepared by depositing a drop of the NPs
suspension after 1 h of incubation at room temperature on a
Formvar® coated copper grid and air-drying at room tempera-
ture.
Acknowledgements
We thank the European Commission for financial support of
this investigation within the GlowBrain project (FP7-
REGPOT–2012–CT2012–316120) and the Czech Science
Foundation (project 16-01128J). We thank Mrs. Iris Elezović
for her great help during preparation of samples for TEM, and
Mr. Makso Herman for his advices during writing.
References
1. Tai, J.-T.; Lai, C.-S.; Ho, H.-C.; Yeh, Y.-S.; Wang, H.-F.; Ho, R.-M.;
Tsai, D.-H. Langmuir 2014, 30, 12755–12764. doi:10.1021/la5033465
2. Lohse, S. E.; Murphy, C. J. J. Am. Chem. Soc. 2012, 134,
15607–15620. doi:10.1021/ja307589n
3. Dominguez-Medina, S.; Blankenburg, J.; Olson, J.; Landes, C. F.;
Link, S. ACS Sustainable Chem. Eng. 2013, 1, 833–842.
doi:10.1021/sc400042h
4. Babič, M.; Horák, D.; Trchová, M.; Jendelová, P.; Glogarová, K.;
Lesný, P.; Herynek, V.; Hájek, M.; Syková, E. Bioconjugate Chem.
2008, 19, 740–750. doi:10.1021/bc700410z
5. Kittler, S.; Greulich, C.; Gebauer, J. S.; Diendorf, J.; Treuel, L.; Ruiz, L.;
Gonzalez-Calbet, J. M.; Vallet-Regi, M.; Zellner, R.; Köller, M.;
Epple, M. J. Mater. Chem. 2010, 20, 512–518. doi:10.1039/B914875B
6. Yen, H.-J.; Hsu, S.-H.; Tsai, C.-L. Small 2009, 5, 1553–1561.
doi:10.1002/smll.200900126
7. Liu, J. Y.; Hurt, R. H. Environ. Sci. Technol. 2010, 44, 2169–2175.
doi:10.1021/es9035557
8. Walters, C.; Pool, E.; Somerset, V. Toxicol. Environ. Chem. 2013, 95,
1690–1701. doi:10.1080/02772248.2014.904141
9. Pettibone, J. M.; Gigault, J.; Hackley, V. A. ACS Nano 2013, 7,
2491–2499. doi:10.1021/nn3058517
10. MacCuspie, R. I.; Allen, A. J.; Hackley, V. A. Nanotoxicology 2011, 5,
140–156. doi:10.3109/17435390.2010.504311
11. Loza, K.; Diendorf, J.; Sengstock, C.; Ruiz-Gonzalez, L.;
Gonzalez-Calbet, J. M.; Vallet-Regi, M.; Köller, M.; Epple, M.
J. Mater. Chem. B 2014, 2, 1634–1643. doi:10.1039/c3tb21569e
12. Liu, J. Y.; Sonshine, D. A.; Shervani, S.; Hurt, R. H. ACS Nano 2010, 4,
6903–6913. doi:10.1021/nn102272n
13. Liu, J. Y.; Wang, Z. Y.; Liu, F. D.; Kane, A. B.; Hurt, R. H. ACS Nano
2012, 6, 9887–9899. doi:10.1021/nn303449n
14. Stebounova, L. V.; Guio, E.; Grassian, V. H. J. Nanopart. Res. 2011,
13, 233–244. doi:10.1007/s11051-010-0022-3
15. Hotze, E. M.; Labille, J.; Alvarez, P.; Wiesner, M. R.
Environ. Sci. Technol. 2008, 42, 4175–4180. doi:10.1021/es702172w
16. Hussain, S. M.; Braydich-Stolle, L. K.; Schrand, A. M.; Murdock, R. C.;
Yu, K. O.; Mattie, D. M.; Schlager, J. J.; Terrones, M. Adv. Mater. 2009,
21, 1549–1559. doi:10.1002/adma.200801395
17. Park, E.-J.; Yi, J.; Kim, Y.; Choi, K.; Park, K. Toxicol. In Vitro 2010, 24,
872–878. doi:10.1016/j.tiv.2009.12.001
18. Zook, J. M.; MacCuspie, R. I.; Locascio, L. E.; Halter, M. D.;
Elliott, J. T. Nanotoxicology 2011, 5, 517–530.
doi:10.3109/17435390.2010.536615
19. Tejamaya, M.; Römer, I.; Merrifield, R. C.; Lead, J. R.
Environ. Sci. Technol. 2012, 46, 7011–7017. doi:10.1021/es2038596
20. Vidic, J.; Haque, F.; Guigner, J. M.; Vidy, A.; Chevalier, C.; Stankic, S.
Langmuir 2014, 30, 11366–11374. doi:10.1021/la501479p
21. Marucco, A.; Catalano, F.; Fenoglio, I.; Turci, F.; Martra, G.; Fubini, B.
Chem. Res. Toxicol. 2015, 28, 87–91. doi:10.1021/tx500366a
22. Leo, B. F.; Chen, S.; Kyo, Y.; Herpoldt, K.-L.; Terrill, N. J.; Dunlop, I. E.;
McPhail, D. S.; Shaffer, M. S.; Schwander, S.; Gow, A.; Zhang, J.;
Chung, K. F.; Tetley, T. D.; Porter, A. E.; Ryan, M. P.
Environ. Sci. Technol. 2013, 47, 11232–11240. doi:10.1021/es403377p
23. Li, X.; Lenhart, J. J.; Walker, H. W. Langmuir 2012, 28, 1095–1104.
doi:10.1021/la202328n
24. MacCuspie, R. I. J. Nanopart. Res. 2011, 13, 2893–2908.
doi:10.1007/s11051-010-0178-x
25. Sharma, V. K.; Siskova, K. M.; Zboril, R.; Gardea-Torresdey, J. L.
Adv. Colloid Interface Sci. 2014, 204, 15–34.
doi:10.1016/j.cis.2013.12.002
26. Jiang, J.; Oberdörster, G.; Biswas, P. J. Nanopart. Res. 2009, 11,
77–89. doi:10.1007/s11051-008-9446-4
27. Gebauer, J. S.; Treuel, L. J. Colloid Interface Sci. 2011, 354, 546–554.
doi:10.1016/j.jcis.2010.11.016
28. Thanh, N. T. K.; Rosenzweig, Z. Anal. Chem. 2002, 74, 1624–1628.
doi:10.1021/ac011127p
29. Schulze, C.; Kroll, A.; Lehr, C.-M.; Schäfer, U. F.; Becker, K.;
Schnekenburger, J.; Schulze Isfort, C.; Landsiedel, R.; Wohlleben, W.
Nanotoxicology 2008, 2, 51–61. doi:10.1080/17435390802018378
30. Gebauer, J. S.; Malissek, M.; Simon, S.; Knauer, S. K.; Maskos, M.;
Stauber, R. H.; Peukert, W.; Treuel, L. Langmuir 2012, 28, 9673–9679.
doi:10.1021/la301104a
31. Segets, D.; Marczak, R.; Schäfer, S.; Paula, C.; Gnichwitz, J.-F.;
Hirsch, A.; Peukert, W. ACS Nano 2011, 5, 4658–4669.
doi:10.1021/nn200465b
32. Kohut, A.; Voronov, A.; Peukert, W. Langmuir 2007, 23, 504–508.
doi:10.1021/la062465u
33. Gilbert, B.; Huang, F.; Zhang, H.; Waychunas, G. A.; Banfield, J. F.
Science 2004, 305, 651–654. doi:10.1126/science.1098454
Beilstein J. Nanotechnol. 2016, 7, 246–262.
261
34. Min, Y.; Akbulut, M.; Kristiansen, K.; Golan, Y.; Israelachvili, J.
Nat. Mater. 2008, 7, 527–538. doi:10.1038/nmat2206
35. Zook, J. M.; Halter, M. D.; Cleveland, D.; Long, S. E. J. Nanopart. Res.
2012, 14, 1165. doi:10.1007/s11051-012-1165-1
36. Treuel, L.; Nienhaus, G. U. Biophys. Rev. 2012, 4, 137–147.
doi:10.1007/s12551-012-0072-0
37. Walczyk, D.; Bombelli, F. B.; Monopoli, M. P.; Lynch, I.; Dawson, K. A.
J. Am. Chem. Soc. 2010, 132, 5761–5768. doi:10.1021/ja910675v
38. Moerz, S. T.; Huber, P. Langmuir 2014, 30, 2729–2737.
doi:10.1021/la404947j
39. Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.;
Bombelli, F. B.; Dawson, K. A. J. Am. Chem. Soc. 2011, 133,
2525–2534. doi:10.1021/ja107583h
40. Lynch, I.; Salvati, A.; Dawson, K. A. Nat. Nanotechnol. 2009, 4,
546–547. doi:10.1038/nnano.2009.248
41. Shannahan, J. H.; Lai, X.; Ke, P. C.; Podila, R.; Brown, J. M.;
Witzmann, F. A. PLoS One 2013, 8, e74001.
doi:10.1371/journal.pone.0074001
42. Park, M. V. D. Z.; Neigh, A. M.; Vermeulen, J. P.;
de la Fonteyne, L. J. J.; Verharen, H. W.; Briedé, J. J.; van Loveren, H.;
de Jong, W. H. Biomaterials 2011, 32, 9810–9817.
doi:10.1016/j.biomaterials.2011.08.085
43. El Badawy, A. M.; Silva, R. G.; Morris, B.; Scheckel, K. G.;
Suidan, M. T.; Tolaymat, T. M. Environ. Sci. Technol. 2011, 45,
283–287. doi:10.1021/es1034188
44. European Commission. Communication from the Commission to the
European Parliament, the Council and the European Economic and
Social Committee. Second regulatory review on nanomaterials.
Brussels, 3.10.2012, COM (2012) 572 final.
45. Martin, M. N.; Allen, A. J.; MacCuspie, R. I.; Hackley, V. A. Langmuir
2014, 30, 11442–11452. doi:10.1021/la502973z
46. Horák, D.; Babič, M.; Jendelová, P.; Herynek, V.; Trchová, M.;
Pientka, Z.; Pollert, E.; Hájek, M.; Syková, E. Bioconjugate Chem.
2007, 18, 635–644. doi:10.1021/bc060186c
47. Horák, D.; Babič, M.; Jendelová, P.; Herynek, V.; Trchová, M.;
Likavčanová, K.; Kapcalová, M.; Hájek, M.; Syková, E.
J. Magn. Magn. Mater. 2009, 321, 1539–1547.
doi:10.1016/j.jmmm.2009.02.082
48. Vinković Vrček, I.; Žuntar, I.; Petlevski, R.; Pavičić, I.; Dutour Sikirić, M.;
Ćurlin, M.; Goessler, W. Environ. Toxicol. 2014, in press.
doi:10.1002/tox.22081
49. Vinković Vrček, I.; Pavičić, I.; Crnković, T.; Jurašin, D.; Babič, M.;
Horák, D.; Lovrić, M.; Ferhatović, L.; Ćurlin, M.; Gajović, S. RSC Adv.
2015, 5, 70787–70807. doi:10.1039/C5RA14100A
50. Milić, M.; Leitinger, G.; Pavičić, I.; Zebić Avdičević, M.; Dobrović, S.;
Goessler, W.; Vinković Vrček, I. J. Appl. Toxicol. 2015, 35, 581–592.
doi:10.1002/jat.3081
51. Kvítek, L.; Panáček, A.; Soukupová, J.; Kolář, M.; Večeřová, R.;
Prucek, R.; Holecová, M.; Zbořil, R. J. Phys. Chem. C 2008, 112,
5825–5834. doi:10.1021/jp711616v
52. Churchman, A. H.; Wallace, R.; Milne, S. J.; Brown, A. P.; Brydson, R.;
Beales, P. A. Chem. Commun. 2013, 49, 4172–4174.
doi:10.1039/c3cc37871c
53. Murdock, R. C.; Braydich-Stolle, L.; Schrand, A. M.; Schlager, J. J.;
Hussain, S. M. Toxicol. Sci. 2008, 101, 239–253.
doi:10.1093/toxsci/kfm240
54. Cedervall, T.; Lynch, I.; Lindman, S.; Berggård, T.; Thulin, E.;
Nilsson, H.; Dawson, K. A.; Linse, S. Proc. Natl. Acad. Sci. U. S. A.
2007, 104, 2050–2055. doi:10.1073/pnas.0608582104
55. Maiorano, G.; Sabella, S.; Sorce, B.; Brunetti, V.; Malvindi, M. A.;
Cingolani, R.; Pompa, P. P. ACS Nano 2010, 4, 7481–7491.
doi:10.1021/nn101557e
56. Simón-Vázquez, R.; Lozano-Fernández, T.; Peleteiro-Olmedo, M.;
González-Fernández, Á. Colloids Surf., B 2014, 113, 198–206.
doi:10.1016/j.colsurfb.2013.08.047
57. Ravindran, A.; Singh, A.; Raichur, A. M.; Chandrasekaran, N.;
Mukherjee, A. Colloids Surf., B 2010, 76, 32–37.
doi:10.1016/j.colsurfb.2009.10.005
58. Yang, Q.; Liang, J.; Han, H. J. Phys. Chem. B 2009, 113,
10454–10458. doi:10.1021/jp904004w
59. Patil, S.; Sandberg, A.; Heckert, E.; Self, W.; Seal, S. Biomaterials
2007, 28, 4600–4607. doi:10.1016/j.biomaterials.2007.07.029
60. Peters, T., Jr. All About Albumin: Biochemistry, Genetics and Medical
Applications, 1st ed.; Academic Press, Inc.: San Diego, CA, USA,
1996.
61. Saptarshi, S. R.; Duschl, A.; Lopata, A. L. J. Nanobiotechnol. 2013, 11,
26. doi:10.1186/1477-3155-11-26
62. Dobrovolskaia, M. A.; Patri, A. K.; Zheng, J.; Clogston, J.; Ayub, D.;
Aggarwal, P.; Neun, B. W.; Hall, J. B.; McNeil, S. E. Nanomedicine
2009, 5, 106–117. doi:10.1016/j.nano.2008.08.001
63. Alkilany, A. M.; Nagaria, P. K.; Hexel, C. R.; Shaw, T. J.; Murphy, C. J.;
Wyatt, M. D. Small 2009, 5, 701–708. doi:10.1002/smll.200801546
64. Khullar, P.; Singh, V.; Mahal, A.; Dave, P. N.; Thakur, S.; Kaur, G.;
Singh, J.; Singh Kamboj, S.; Singh Bakshi, M. J. Phys. Chem. C 2012,
116, 8834–8843. doi:10.1021/jp300585d
65. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G. J.; Puntes, V.
ACS Nano 2010, 4, 3623–3632. doi:10.1021/nn901372t
66. Xia, Y.; Xiong, Y.; Lim, B.; Skrabalak, S. E. Angew. Chem., Int. Ed.
2008, 48, 60–103. doi:10.1002/anie.200802248
67. Goesmann, H.; Feldmann, C. Angew. Chem., Int. Ed. 2010, 49,
1362–1395. doi:10.1002/anie.200903053
68. Klaus-Joerger, T.; Joerger, R.; Olsson, E.; Granqvist, C.-G.
Trends Biotechnol. 2001, 19, 15–20.
doi:10.1016/S0167-7799(00)01514-6
69. Lowenstam, H. A. Science 1981, 211, 1126–1131.
doi:10.1126/science.7008198
70. Spring, S.; Schleifer, K.-H. Syst. Appl. Microbiol. 1995, 18, 147–153.
doi:10.1016/S0723-2020(11)80386-3
71. Schüler, D.; Frankel, R. B. Appl. Microbiol. Biotechnol. 1999, 52,
464–473. doi:10.1007/s002530051547
72. Kajander, E. O.; Çiftçioglu, N. Proc. Natl. Acad. Sci. U. S. A. 1998, 95,
8274–8279. doi:10.1073/pnas.95.14.8274
73. Rivadeneyra, M.-A.; Delgado, G.; Soriano, M.;
Ramos-Cormenzana, A.; Delgado, R. Curr. Microbiol. 1999, 39, 53–57.
doi:10.1007/PL00006827
74. Keefe, W. E. Infect. Immun. 1976, 14, 590–592.
75. Klaus, T.; Joerger, R.; Olsson, E.; Granqvist, C.-G.
Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 13611–13614.
doi:10.1073/pnas.96.24.13611
Beilstein J. Nanotechnol. 2016, 7, 246–262.
262
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of
Nanotechnology terms and conditions:
(http://www.beilstein-journals.org/bjnano)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjnano.7.23
